Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 6/2017

01-06-2017 | Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Sphenopalatine Ganglion Block in the Management of Chronic Headaches

Authors: Jeffery Mojica, Bi Mo, Andrew Ng

Published in: Current Pain and Headache Reports | Issue 6/2017

Login to get access

Abstract

Purpose of Review

Sphenopalatine ganglion (SPG) block has been used by clinicians in the treatment of a variety of headache disorders, facial pain syndromes, and other facial neuralgias. The sensory and autonomic fibers that travel through the SPG provided the scientific rationale for symptoms associated with these head and neck syndromes. Yet, despite the elucidation of this pathogenic target, the optimal method to block its pain-producing properties has not been determined. Clinicians have developed various invasive and non-invasive techniques, each of which has shown variable rates of success. We examined the available studies of sphenopalatine ganglion blockade and its efficacy in the treatment of cluster headaches, migraines, and other trigeminal autonomic cephalalgias.

Recent Findings

Studies have demonstrated that SPG blockade and neurostimulation can provide pain relief in patients with cluster headaches, migraines, and other trigeminal autonomic cephalalgias. Patients with these conditions showed varying levels and duration of pain relief from SPG blockade. The efficacy of SPG blockade could be related to the different techniques targeting the SPG and choice of therapeutic agents.

Summary

Based on current studies, SPG blockade is a safe and effective treatment for chronic headaches such as cluster headaches, migraines, and other trigeminal autonomic cephalalgias. Future studies are warranted to define the optimal image-guided technique and choice of pharmacologic agents for SPG blockade as an effective treatment for chronic headaches related to activation of the sphenopalatine ganglion.
Literature
1.
Rusu MC, Pop F, Curcă GC, Podoleanu L, Voinea LM. The pterygopalatine ganglion in humans: a morphological study. Annals of Anatomy-Anatomischer Anzeiger. 2009;191(2):196–202.CrossRef
2.
Rusu MC, Pop F. The anatomy of the sympathetic pathway through the pterygopalatine fossa in humans. Annals of Anatomy-Anatomischer Anzeiger. 2010;192(1):17–22.CrossRef
3.
Moore KL, Dalley AF, Agur AM. Clinically oriented anatomy. Lippincott Williams & Wilkins; 2013.
4.
Robbins MS, Robertson CE, Kaplan E, Ailani J, Charleston L, Kuruvilla D, Blumenfeld A, Berliner R, Rosen NL, Duarte R, Vidwan J. The sphenopalatine ganglion: anatomy, pathophysiology, and therapeutic targeting in headache. Headache: J Head Face Pain. 2015.
5.
Ruskell GL. Distribution of pterygopalatine ganglion efferents to the lacrimal gland in man. Exp Eye Res. 2004;78(3):329–35.CrossRefPubMed
6.
•• Piagkou M, Demesticha T, Troupis T, Vlasis K, Skandalakis P, Makri A, Mazarakis A, Lappas D, Piagkos G, Johnson EO. The pterygopalatine ganglion and its role in various pain syndromes: from anatomy to clinical practice. Pain Practice. 2012;12(5):399–412. This article highlights the pathophysiology of headaches related to sphenopalatine ganglion activation and different techniques of sphenopalatine ganglion blocks.
7.
Tubbs RS, Menendez J, Loukas M, Shoja MM, Shokouhi G, Salter EG, Cohen-Gadol A. The petrosal nerves: anatomy, pathology, and surgical considerations. Clin Anat. 2009;22(5):537–44.CrossRefPubMed
8.
9.
May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999;19(2):115–27.CrossRefPubMed
10.
Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117(3):427–34.CrossRefPubMed
11.
Yarnitsky D, Goor-Aryeh I, Bajwa ZH, Ransil BI, Cutrer FM, Sottile A, Burstein R. 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache: The Journal of Head and Face Pain. 2003;43(7):704–14.CrossRef
12.
Headache classification committee of the international headache society (IHS). The international classification of headache disorders, (beta version). Cephalalgia. 2013;33(9):629–808.
13.
14.
May A, Leone M, Afra J, Linde M, Sandor PS, Evers S, Goadsby PJ. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13(10):1066–77.CrossRefPubMed
15.
Morelli N, Mancuso M, Felisati G, Lozza P, Maccari A, Cafforio G, Gori S, Murri L, Guidetti D. Does sphenopalatine endoscopic ganglion block have an effect in paroxysmal hemicrania? A case report. Cephalalgia. 2010;30(3):365–7.CrossRefPubMed
16.
Michelle Androulakis X, Krebs KA, Ashkenazi A. Hemicrania continua may respond to repetitive sphenopalatine ganglion block: a case report. Headache: J Head Face Pain. 2016.
17.
Devoghel JC. Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg. 1980;32(1):101–7.
18.
Barre F. Cocaine as an abortive agent in cluster headache. Headache: The Journal of Head and Face Pain. 1982;22(2):69–73.CrossRef
19.
Kittrelle JP, Grouse DS, Seybold ME. Cluster headache: local anesthetic abortive agents. Arch Neurol. 1985;42(5):496–8.CrossRefPubMed
20.
Robbins L. Intranasal lidocaine for cluster headache. Headache: The Journal of Head and Face Pain. 1995;35(2):83–4.CrossRef
21.
Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, Nappi G. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia. 2000;20(2):85–91.CrossRefPubMed
22.
Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg. 1997;87(6):876–80.CrossRefPubMed
23.
Narouze S, Kapural L, Casanova J, Mekhail N. Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache: The Journal of Head and Face Pain. 2009;49(4):571–7.CrossRef
24.
Loomba V, Upadhyay A, Kaveeshvar H. Radiofrequency ablation of the sphenopalatine ganglion using cone beam computed tomography for intractable cluster headache. Pain Physician. 2016;19:E1093–6.PubMed
25.
Chua NH, Vissers KC, Wilder-Smith OH. Quantitative sensory testing may predict response to sphenopalatine ganglion pulsed radiofrequency treatment in cluster headaches: a case series. Pain practice. 2011;11(5):439–45.CrossRefPubMed
26.
Fang L, Jingjing L, Ying S, Lan M, Tao W, Nan J. Computerized tomography-guided sphenopalatine ganglion pulsed radiofrequency treatment in 16 patients with refractory cluster headaches: twelve- to 30-month follow-up evaluations. Cephalalgia. 2016;36(2):106–12.CrossRefPubMed
27.
Van Bets B, Raets I, Gypen E, Mestrum R, Heylen R, Van Zundert J. Pulsed radiofrequency treatment of the pterygopalatine (sphenopalatine) ganglion in cluster headache: a 10 year retrospective analysis: 14AP7-5. European Journal of Anaesthesiology (EJA). 2014;31:233.CrossRef
28.
Bendersky DC, Hem SM, Yampolsky CG. Unsuccessful pulsed radiofrequency of the sphenopalatine ganglion in patients with chronic cluster headache and subsequent successful thermocoagulation. Pain Practice. 2015;15(5):E40–5.CrossRefPubMed
29.
Kudrow L, Kudrow DB, Sandweiss JH. Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache: The Journal of Head and Face Pain. 1995;35(2):79–82.CrossRef
30.
Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA. 1996;276(4):319–21.CrossRefPubMed
31.
Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache: The Journal of Head and Face Pain. 1999;39(8):543–51.CrossRef
32.
•• Cady R, Saper J, Dexter K, Manley HR. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360® as acute treatment for chronic migraine. Headache: The Journal of Head and Face Pain. 2015;55(1):101–16. This article demonstrates the efficacy of sphenopalatine ganglion block with bupivacaine. CrossRef
33.
•• Bratbak DF, Nordgård S, Stovner LJ, Linde M, Dodick DW, Aschehoug I, Folvik M, Tronvik E. Pilot study of sphenopalatine injection of onabotulinum toxin A for the treatment of intractable chronic migraine. Cephalalgia. 2016. It is a novel approach to utilize onabotulinum toxin A as a pharmacologic agent for sphenopalatine ganglion block.
34.
Sluder G. The anatomical and clinical relations of the sphenopalatine (Meckel’s) ganglion to the nose and its accessory sinuses. AR Elliott Publishing Company; 1909.
35.
Felisati G, Arnone F, Lozza P, Leone M, Curone M, Bussone G. Sphenopalatine endoscopic ganglion block: a revision of a traditional technique for cluster headache. Laryngoscope. 2006;116(8):1447–50.CrossRefPubMed
36.
Higuchi Y, Nashold BS, Sluijter M, Cosman E, Pearlstein RD. Exposure of the dorsal root ganglion in rats to pulsed radiofrequency currents activates dorsal horn lamina I and II neurons. Neurosurgery-Baltimore. 2002;50(4):850–6.CrossRef
Metadata
Title
Sphenopalatine Ganglion Block in the Management of Chronic Headaches
Authors
Jeffery Mojica
Bi Mo
Andrew Ng
Publication date
01-06-2017
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 6/2017
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-017-0626-8

Other articles of this Issue 6/2017

Current Pain and Headache Reports 6/2017 Go to the issue

Other Pain (N Vadivelu and A Kaye, Section Editors)

Indications for Opioid Antagonists

Neuropathic Pain (E Eisenberg, Section Editor)

Neuropathic Pain: Central vs. Peripheral Mechanisms

Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)

Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment

Chronic Daily Headache (SJ Wang, Section Editor)

Treatment Update of Chronic Migraine